This study aims to investigate T-lymphocyte subsets (CD4+, CD8+) and T-lymphocyte activation (CD69+, CD25+, and HLA-DR+) in peripheral blood from children with HL to identify the potential prognostic factors for event-free survival (EFS). This evidence concerns the gene CD69 and Hodgkins lymphoma.